[go: up one dir, main page]

MX9709004A - Benzopiranos. - Google Patents

Benzopiranos.

Info

Publication number
MX9709004A
MX9709004A MX9709004A MX9709004A MX9709004A MX 9709004 A MX9709004 A MX 9709004A MX 9709004 A MX9709004 A MX 9709004A MX 9709004 A MX9709004 A MX 9709004A MX 9709004 A MX9709004 A MX 9709004A
Authority
MX
Mexico
Prior art keywords
benzopyrans
pharmaceutical compositions
compositions containing
alkyl
carbon atoms
Prior art date
Application number
MX9709004A
Other languages
English (en)
Other versions
MXPA97009004A (es
Inventor
Paul W Manley
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10774940&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX9709004(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MX9709004A publication Critical patent/MX9709004A/es
Publication of MXPA97009004A publication Critical patent/MXPA97009004A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/70Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

La invencion proporciona novedosos 2,2-di(alquilo de 1 a 5 átomos de carbono)-o trans-2,2-di(alquilo de 1 a 5 átomos de carbono)-3,4-dihidro-3-hidroxi- -4-carboxamido-6-(N-arilsulfonamido)-2H-1-benzopir anos; y N-oxidos, ésteres, y sales de los mismos; procesos para su produccion y sus usos como productos farmacéuticos, por ejemplo, como abridores del canal de K+, broncodilatadores, y agentes para la supresion de la hiperreactividad de las vías aéreas, por ejemplo, para utilizarse en el tratamiento de asma.
MXPA/A/1997/009004A 1995-05-24 1997-11-21 Benzopiranos MXPA97009004A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9510477.4 1995-05-24
GBGB9510477.4A GB9510477D0 (en) 1995-05-24 1995-05-24 Organic compounds
PCT/EP1996/002257 WO1996037490A1 (en) 1995-05-24 1996-05-24 Benzopyrans and pharmaceutical compositions containing them

Publications (2)

Publication Number Publication Date
MX9709004A true MX9709004A (es) 1998-03-31
MXPA97009004A MXPA97009004A (es) 1998-10-15

Family

ID=

Also Published As

Publication number Publication date
RU2160735C2 (ru) 2000-12-20
CO4700520A1 (es) 1998-12-29
SK157797A3 (en) 1998-05-06
IL118382A0 (en) 1996-09-12
FI973992A7 (fi) 1997-12-09
HK1014137A1 (en) 1999-09-24
DE69615019T2 (de) 2002-06-06
AU6000896A (en) 1996-12-11
GB9510477D0 (en) 1995-07-19
CZ294474B6 (cs) 2005-01-12
KR100437981B1 (ko) 2004-07-16
HUP9801751A2 (hu) 1999-06-28
PL324042A1 (en) 1998-05-11
DK0828733T3 (da) 2001-12-17
CA2217821C (en) 2008-05-06
CA2217821A1 (en) 1996-11-28
NZ309765A (en) 2000-01-28
CZ368897A3 (cs) 1998-02-18
CN1077888C (zh) 2002-01-16
SK283215B6 (sk) 2003-03-04
KR19990021925A (ko) 1999-03-25
PT828733E (pt) 2002-02-28
EP0828733B1 (en) 2001-09-05
NO975365L (no) 1998-01-15
JPH11505820A (ja) 1999-05-25
ES2163634T3 (es) 2002-02-01
HUP9801751A3 (en) 1999-08-30
PL184144B1 (pl) 2002-09-30
ATE205204T1 (de) 2001-09-15
FI973992L (fi) 1997-12-09
US5905156A (en) 1999-05-18
AU703276B2 (en) 1999-03-25
CN1185153A (zh) 1998-06-17
AR004489A1 (es) 1998-12-16
TR199701417T1 (xx) 1998-02-21
DE69615019D1 (de) 2001-10-11
IL118382A (en) 2000-01-31
ZA964209B (en) 1997-11-24
TW421646B (en) 2001-02-11
MY114924A (en) 2003-02-28
BR9609048A (pt) 1999-02-23
WO1996037490A1 (en) 1996-11-28
FI973992A0 (fi) 1997-10-17
HU222772B1 (hu) 2003-10-28
NO975365D0 (no) 1997-11-21
NO314846B1 (no) 2003-06-02
EP0828733A1 (en) 1998-03-18

Similar Documents

Publication Publication Date Title
GT199900131A (es) Derivados del acido hidroxi-pipecolato hidroxamico.
ES2178779T3 (es) Nuevas amidas de acidos de piridil alcanos como agentes citoestaticos e inmunosupresores.
ES2179351T3 (es) Amidas acidas de piridil alqueno y piridil alquino como citoestaticos e inmunosupresores.
GT200500007A (es) [1,8]naftiridin-2-onas y compuestos relacionados para el tratamiento de la esquizofrenia.
MX9700890A (es) 1, 4-benzotiazepina-1, 1-dioxidos hipolipidemicos.
ECSP034732A (es) Derivado de fenetanolamina para el tratamiento de enfermedades respiratorias
ES2150983T3 (es) Productos proteicos bactericidas estables que incrementan la permeabilidad y composiciones farmaceuticas que los contienen.
UY28510A1 (es) Compuestos quimicos
ES2096262T3 (es) Nuevas cyclosporins modificadas en la posicion 1.
ES2176480T3 (es) Derivados acilados de la melatonina y de analogos como medicamentos.
ES2164842T3 (es) Procedimiento para la preparacion de composiciones de microcapsulas.
ECSP045003A (es) Nuevas dihidro-pteridinonas, procedimientos para su preparación y su utilización como medicamentos.
SV1999000048A (es) Uso de dihidropiriminas como medicamento y nuevas sustancias ref. lea 32 791-sv
ES2115175T3 (es) Nuevas composiciones a base de agua oxigenada y su utilizacion como fijadores para permanentes.
BRPI0409680A (pt) análogos de fosfonato anti-cáncer
MX9707636A (es) Ascomicinas.
BR0311347A (pt) Alcanóis bis-aromáticos
ES2115904T3 (es) Derivados amino ramificados del tiazol, sus procedimientos de preparacion y las composiciones farmaceuticas que los contienen.
AR012193A1 (es) Nuevas combinaciones terapeuticas
MX9307232A (es) Arilcicloalquilaminas n,n-disustituidas, sus sales, medicamentos que contiene estos compuestos y su empleo, asi como procedimientos para su preparacion.
AR016973A1 (es) Uso de aminometil-cromanos sustituidos para la produccion de un medicamento util para el tratamiento de enfermedades neurodegenerativas y para el estimulode la regeneracion neuronal
BR0309085A (pt) Medicamento que contém esteróides e agente anticolinérgico
ES2163634T3 (es) Benzopiranos y composiciones farmaceuticas que les contienen.
BRPI0416188A (pt) formulações de medicamentos que contêm aromatizante, com propriedades farmacêuticas aperfeiçoadas
BR0212246A (pt) Composição indutora da resistência a doença de planta, método para controlar uma doença de planta, e, processo para a produção de uma composição